glp-1 drugs for pcos and PCOS: A Promising Tool, But Not a Quick Fix Liraglutide and polycystic ovary syndrome:

Indian J

2 Researchers are still studying the mechanism and effects of GLP-1 drugs in other tissues where the GLP-1 receptor is expressed, including the brain, heart, and immune system

The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74

With semaglutide GLP-1 , many patients start to see significant weight loss within the first few weeks of treatment, with most experiencing a noticeable reduction in appetite and weight loss after about 46 weeks

Here, GLP-1RAs are one exciting option [28]

Drug Type/Class 15.5.3